Valion Bio's total assets for Q2 2026 were $56.75M, an increase of 83348.63% from the previous quarter. VBIO total liabilities were $49.04M for the fiscal quarter, a 31401.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.